Plasma Methylglyoxal Levels Are Associated With Amputations and Mortality in Severe Limb Ischemia Patients With and Without Diabetes.

Nordin M J HanssenNordin M J HanssenJean L J M ScheijenMarjo Van de WaarenburgHendrik GremmelsCoen D A StehouwerMarianne C VerhaarMiranda T Schram

Published in: Diabetes care (2020)

Plasma MGO levels are associated with adverse outcomes in SLI. Future studies should investigate whether MGO-targeting therapies improve outcomes in SLI.

Keyphrases

type diabetes
cardiovascular disease
glycemic control
cardiovascular events
current status
cancer therapy
skeletal muscle
drug induced
weight loss